# Fengliao Changweikang for Diarrhea-predominant Irritable Bowel Syndrome: N-of-1 Trial

> **NCT07061184** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Peking Union Medical College Hospital** · enrollment: 50 (estimated)

## Conditions studied

- Irritable Bowel Syndrome - Diarrhoea
- Traditional Chinese Medicine (TCM)
- N of 1 Study Design
- Efficacy and Safety

## Interventions

- **DRUG:** FLCWK
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07061184
- **Lead sponsor:** Peking Union Medical College Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-11
- **Primary completion:** 2027-11
- **Final completion:** 2028-05
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2025-07-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07061184

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07061184, "Fengliao Changweikang for Diarrhea-predominant Irritable Bowel Syndrome: N-of-1 Trial". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT07061184. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*